{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:51:24Z","timestamp":1781639484087,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Natural Science Foundation of China (NSFC) General Program","award":["82271863"],"award-info":[{"award-number":["82271863"]}]},{"name":"Beijing Natural Science Foundation General Program","award":["7242166"],"award-info":[{"award-number":["7242166"]}]},{"name":"Peking University Third Hospital Obstetrics and Gynecology Open Research Fund","award":["BYSYSZKF2022008, BYSYSZKF2023011"],"award-info":[{"award-number":["BYSYSZKF2022008, BYSYSZKF2023011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In vitro maturation (IVM) presents a potential alternative to conventional IVF for special subgroups of infertile couples. Anti-M\u00fcllerian Hormone (AMH) is widely regarded as the most robust biomarker for assessing ovarian reserve. However, the relationship between AMH and subsequent pregnancy success rates following IVM remains poorly characterized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>\n                      This was a retrospective cohort study. Infertile patients undergoing IVM treatment at Peking University Third Hospital Reproductive Medicine Center between January 2016 and June 2024. Participants were stratified by AMH (ng\/ml) quartiles: Group A (1\u2009&lt;\u2009AMH\u2009\u2264\u20097.77,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200999), B (7.77\u2009&lt;\u2009AMH\u2009\u2264\u200911.91,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200998), C (11.91\u2009&lt;\u2009AMH\u2009\u2264\u200917.53,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009100), and D (AMH\u2009&gt;\u200917.53,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200996). The primary outcome was cumulative live birth rate.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      While baseline characteristics (age, BMI, infertility duration\/type, FSH) were comparable across groups, Group D demonstrated significantly higher immature oocyte yield (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), and embryological parameters (transferable\/high-quality embryos:\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) versus other groups. Paradoxically, Group A achieved superior clinical outcomes, including: cumulative live birth rate (48.8% vs. 29.1% vs. 37.7% vs. 21.6%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.009), cumulative clinical pregnancy rate (67.4% vs. 40.0% vs. 42.6% vs. 36.1%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.006), and clinical pregnancy rate (68.4% vs. 39.1% vs. 44.4% vs. 37.5%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.015). Multivariate analysis also indicated that excessively high AMH levels (&gt;\u200917.53ng\/ml) may be related to reduced clinical pregnancy rate compared to low AMH levels (\n                      <jats:italic>OR<\/jats:italic>\n                      \u2009=\u20090.281, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      : 0.108\u20130.728,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.009). No significant differences emerged between fresh versus frozen-thawed transfers.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Elevated AMH levels (&gt;\u200917.53ng\/ml) predict enhanced follicular recruitment but paradoxically associate with diminished reproductive success compared to moderate AMH levels (1\u2009&lt;\u2009AMH\u2009\u2264\u20097.77 ng\/ml) in IVM cycles.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13048-026-02033-w","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T09:43:34Z","timestamp":1772012614000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of anti-M\u00fcllerian hormone on pregnancy outcomes in in vitro maturation: a retrospective cohort study"],"prefix":"10.1186","volume":"19","author":[{"given":"Mengjie","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjing","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donglin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"issue":"1","key":"2033_CR1","doi-asserted-by":"publisher","first-page":"18555","DOI":"10.1038\/s41598-020-75699-x","volume":"10","author":"N Sermondade","year":"2020","unstructured":"Sermondade N, Grynberg M, Comtet M, et al. Double-in vitro maturation increases the number of vitrified oocytes available for fertility preservation when ovarian stimulation is unfeasible [J]. Sci Rep. 2020;10(1):18555.","journal-title":"Sci Rep"},{"issue":"1","key":"2033_CR2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0015-0282(16)54068-0","volume":"55","author":"KY Cha","year":"1991","unstructured":"Cha KY, Ko JJ, Choi DH, et al. Pregnancy after in vitro fertilization of human follicular oocytes collected from nonstimulated cycles, their culture in vitro and their transfer in a donor oocyte program [J]. Fertil Steril. 1991;55(1):109\u201313.","journal-title":"Fertil Steril"},{"issue":"1","key":"2033_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/OGX.0000000000000150","volume":"70","author":"MT Sauerbrun-Cutler","year":"2015","unstructured":"Sauerbrun-Cutler MT, Vega M, Keltz M, et al. In vitro maturation and its role in clinical assisted reproductive technology [J]. Obstet Gynecol Surv. 2015;70(1):45\u201357. https:\/\/doi.org\/10.1097\/OGX.0000000000000150.","journal-title":"Obstet Gynecol Surv"},{"issue":"1","key":"2033_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.rbmo.2020.09.022","volume":"42","author":"SC Braam","year":"2021","unstructured":"[4] Braam SC, Ho VNA, Pham TD, et al. In-vitro maturation versus IVF: a cost-effectiveness analysis [J]. Reprod Biomed Online. 2021;42(1):143\u20139. https:\/\/doi.org\/10.1016\/j.rbmo.2020.09.022.","journal-title":"Reprod Biomed Online"},{"key":"2033_CR5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.bpobgyn.2018.06.004","volume":"53","author":"ML Walls","year":"2018","unstructured":"Walls ML, Hart RJ. In vitro maturation [J]. Best Pract Res Clin Obstet Gynaecol. 2018;53:60\u201372. https:\/\/doi.org\/10.1016\/j.bpobgyn.2018.06.004.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"2","key":"2033_CR6","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.fertnstert.2020.11.018","volume":"115","author":"Practice Committees of the American Society for Reproductive Medicine","year":"2021","unstructured":"Practice Committees of the American Society for Reproductive Medicine. The society of reproductive biologists and Technologists, and the society for assisted reproductive Technology. In vitro maturation: a committee opinion [J]. Fertil Steril. 2021;115(2):298\u2013304. https:\/\/doi.org\/10.1016\/j.fertnstert.2020.11.018.","journal-title":"Fertil Steril"},{"issue":"12","key":"2033_CR7","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1007\/s10815-018-1317-z","volume":"35","author":"A Galv\u00e3o","year":"2018","unstructured":"Galv\u00e3o A, Segers I, Smitz J, et al. In vitro maturation (IVM) of oocytes in patients with resistant ovary syndrome and in patients with repeated deficient oocyte maturation [J]. J Assist Reprod Genet. 2018;35(12):2161\u201371. https:\/\/doi.org\/10.1007\/s10815-018-1317-z.","journal-title":"J Assist Reprod Genet"},{"issue":"1","key":"2033_CR8","doi-asserted-by":"publisher","first-page":"2579425","DOI":"10.1080\/01443615.2025.2579425","volume":"46","author":"Y Lv","year":"2026","unstructured":"Lv Y, Wu S, Miao M, et al. Success of oocyte retrieval in modified natural cycle assisted reproductive techniques: a retrospective cohort study [J]. J Obstet Gynaecol. 2026;46(1):2579425. https:\/\/doi.org\/10.1080\/01443615.2025.2579425.","journal-title":"J Obstet Gynaecol"},{"issue":"12","key":"2033_CR9","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1080\/09603123.2025.2506136","volume":"35","author":"X Huang","year":"2025","unstructured":"Huang X, Chen J, Yu Y, et al. The impact of polycyclic aromatic hydrocarbon metabolites on reproductive hormone levels and follicle count in patients with polycystic ovary syndrome: a case-control study [J]. Int J Environ Health Res. 2025;35(12):3977\u201388. https:\/\/doi.org\/10.1080\/09603123.2025.2506136.","journal-title":"Int J Environ Health Res"},{"issue":"2","key":"2033_CR10","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/ijc.31058","volume":"142","author":"SA-O Jung","year":"2018","unstructured":"Jung SA-O, Allen N, Arslan AA, et al. Anti-M\u00fcllerian hormone and risk of ovarian cancer in nine cohorts [J]. Int J Cancer. 2018;142(2):262\u201370. https:\/\/doi.org\/10.1002\/ijc.31058.","journal-title":"Int J Cancer"},{"issue":"2","key":"2033_CR11","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s10815-024-03341-0","volume":"42","author":"MA-O Zhang","year":"2025","unstructured":"Zhang MA-O, Feng J, Ma W, et al. Current status of fertility preservation procedures in gynecologic oncology: from a Chinese perspective [J]. J Assist Reprod Genet. 2025;42(2):635\u201345. https:\/\/doi.org\/10.1007\/s10815-024-03341-0.","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"2033_CR12","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1136\/ijgc-2020-001754","volume":"31","author":"E Bunyaeva","year":"2021","unstructured":"Bunyaeva E, Kirillova A, Khabas G, et al. Feasibility of in vitro maturation of oocytes collected from patients with malignant ovarian tumors undergoing fertility preservation [J]. Int J Gynecol Cancer. 2021;31(3):475\u20139. https:\/\/doi.org\/10.1136\/ijgc-2020-001754.","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"2033_CR13","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1093\/humupd\/dmab044","volume":"28","author":"JA-O Buratini","year":"2022","unstructured":"Buratini JA-O, Dellaqua TT, Dal Canto M, et al. The putative roles of FSH and AMH in the regulation of oocyte developmental competence: from fertility prognosis to mechanisms underlying age-related subfertility [J]. Hum Reprod Update. 2022;28(2):232\u201354. https:\/\/doi.org\/10.1093\/humupd\/dmab044.","journal-title":"Hum Reprod Update"},{"issue":"3","key":"2033_CR14","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/humupd\/dmac045","volume":"29","author":"SA-O Nelson","year":"2023","unstructured":"Nelson SA-O, Davis S, A-O, Kalantaridou S, A-O, et al. Anti-M\u00fcllerian hormone for the diagnosis and prediction of menopause: a systematic review [J]. Hum Reprod Update. 2023;29(3):327\u201346. https:\/\/doi.org\/10.1093\/humupd\/dmac045.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"2033_CR15","doi-asserted-by":"publisher","first-page":"100091","DOI":"10.1016\/j.xinn.2021.100091","volume":"2","author":"H Xu","year":"2021","unstructured":"Xu H, Zhang M, Zhang H, et al. Clinical applications of serum anti-M\u00fcllerian hormone measurements in both males and females: an update [J]. Innov (Camb). 2021;2(1):100091. https:\/\/doi.org\/10.1016\/j.xinn.2021.100091.","journal-title":"Innov (Camb)"},{"issue":"14","key":"2033_CR16","doi-asserted-by":"publisher","first-page":"1074347","DOI":"10.3389\/fendo.2023.1074347","volume":"20","author":"C Ma","year":"2023","unstructured":"Ma C, Xu H, Wang H, et al. An online tool for predicting ovarian responses in unselected patients using dynamic inhibin B and basal antim\u00fcllerian hormone levels [J]. Front Endocrinol (Lausanne). 2023;20(14):1074347. https:\/\/doi.org\/10.3389\/fendo.2023.1074347.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"13","key":"2033_CR17","doi-asserted-by":"publisher","first-page":"821368","DOI":"10.3389\/fendo.2022.821368","volume":"17","author":"H Xu","year":"2022","unstructured":"Xu H, Feng G, Alpadi K, et al. A model for predicting polycystic ovary syndrome using serum AMH, menstrual cycle Length, body mass index and serum Androstenedione in Chinese reproductive aged population: A retrospective cohort study [J]. Front Endocrinol (Lausanne). 2022;17(13):821368. https:\/\/doi.org\/10.3389\/fendo.2022.821368.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2033_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12958-023-01153-y","volume":"21","author":"T Yuwen","year":"2023","unstructured":"Yuwen T, Yang Z, Cai G, et al. Association between serum AMH levels and IVF\/ICSI outcomes in patients with polycystic ovary syndrome: a systematic review and meta-analysis [J]. Reprod Biol Endocrinol. 2023;21(1):95. https:\/\/doi.org\/10.1186\/s12958-023-01153-y.","journal-title":"Reprod Biol Endocrinol"},{"issue":"2","key":"2033_CR19","doi-asserted-by":"publisher","first-page":"126","DOI":"10.5653\/cerm.2016.43.2.126","volume":"43","author":"HH Seok","year":"2016","unstructured":"Seok HH, Song H, Lyu SW, et al. Application of serum anti-M\u00fcllerian hormone levels in selecting patients with polycystic ovary syndrome for in vitro maturation treatment [J]. Clin Exp Reprod Med. 2016;43(2):126\u201332. https:\/\/doi.org\/10.5653\/cerm.2016.43.2.126.","journal-title":"Clin Exp Reprod Med"},{"issue":"12","key":"2033_CR20","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1007\/s10815-023-02958-x","volume":"40","author":"K Ito","year":"2023","unstructured":"Ito K, Takae S, Nakamura K, et al. The study of the efficiency of in vitro maturation of ovarian tissue oocytes in pediatric patients [J]. J Assist Reprod Genet. 2023;40(12):2787\u201397. https:\/\/doi.org\/10.1007\/s10815-023-02958-x.","journal-title":"J Assist Reprod Genet"},{"issue":"2","key":"2033_CR21","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/humrep\/deab243","volume":"37","author":"X Zheng","year":"2022","unstructured":"Zheng X, Guo W, Zeng L, et al. In vitro maturation without gonadotropins versus in vitro fertilization with hyperstimulation in women with polycystic ovary syndrome: a non-inferiority randomized controlled trial [J]. Hum Reprod. 2022;37(2):242\u201353. https:\/\/doi.org\/10.1093\/humrep\/deab243.","journal-title":"Hum Reprod"},{"key":"2033_CR22","doi-asserted-by":"crossref","unstructured":"Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology. The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting [J]. Hum Reprod Open. 2011; 26(6): 1270\u20131283.","DOI":"10.1016\/j.rbmo.2011.02.001"},{"issue":"6","key":"2033_CR23","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0015-0282(00)00518-5","volume":"73","author":"DK Gardner","year":"2000","unstructured":"Gardner DK, L M. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer [J]. Fertil Steril. 2000;73(6):1155\u20138.","journal-title":"Fertil Steril"},{"issue":"7","key":"2033_CR24","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s10815-022-02541-w","volume":"39","author":"S Colaco","year":"2022","unstructured":"Colaco S, A-O, Achrekar SA-O, Patil A, et al. Association of AMH and AMHR2 gene polymorphisms with ovarian response and pregnancy outcomes in Indian women [J]. J Assist Reprod Genet. 2022;39(7):1633\u201342. https:\/\/doi.org\/10.1007\/s10815-022-02541-w.","journal-title":"J Assist Reprod Genet"},{"issue":"9","key":"2033_CR25","doi-asserted-by":"publisher","first-page":"e3714","DOI":"10.1210\/clinem\/dgac370","volume":"107","author":"L Moolhuijsen","year":"2022","unstructured":"Moolhuijsen L, Louwers Y, Laven J, et al. Comparison of 3 different AMH assays with AMH levels and follicle count in women with polycystic ovary syndrome [J]. J Clin Endocrinol Metab. 2022;107(9):e3714\u201322. https:\/\/doi.org\/10.1210\/clinem\/dgac370.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2033_CR26","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.fertnstert.2024.09.010","volume":"123","author":"LN Vuong","year":"2025","unstructured":"Vuong LN, Ho VNA, Le AH, et al. Hormone-free vs. follicle-stimulating hormone-primed infertility treatment of women with polycystic ovary syndrome using biphasic in vitro maturation: a randomized controlled trial [J]. Fertil Steril. 2025;123(2):253\u201361. https:\/\/doi.org\/10.1016\/j.fertnstert.2024.09.010.","journal-title":"Fertil Steril"},{"issue":"11","key":"2033_CR27","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1093\/humrep\/deaa240","volume":"35","author":"LN Vuong","year":"2020","unstructured":"Vuong LN, Ho VNA, Ho TM, et al. In-vitro maturation of oocytes versus conventional IVF in women with infertility and a high antral follicle count: a randomized non-inferiority controlled trial [J]. Hum Reprod. 2020;35(11):2537\u201347. https:\/\/doi.org\/10.1093\/humrep\/deaa240.","journal-title":"Hum Reprod"},{"issue":"8","key":"2033_CR28","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1093\/humrep\/dez086","volume":"34","author":"L Mostinckx","year":"2019","unstructured":"Mostinckx L, Segers I, Belva F, et al. Obstetric and neonatal outcome of ART in patients with polycystic ovary syndrome: IVM of oocytes versus controlled ovarian stimulation [J]. Hum Reprod. 2019;34(8):1595\u2013607. https:\/\/doi.org\/10.1093\/humrep\/dez086.","journal-title":"Hum Reprod"},{"issue":"1","key":"2033_CR29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/humrep\/deu248","volume":"30","author":"ML Walls","year":"2015","unstructured":"Walls ML, Hunter T, Ryan JP, et al. In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes [J]. Hum Reprod. 2015;30(1):88\u201396. https:\/\/doi.org\/10.1093\/humrep\/deu248.","journal-title":"Hum Reprod"},{"key":"2033_CR30","doi-asserted-by":"crossref","unstructured":"Guzman L, O-H C. P. P N, A prediction model to select PCOS patients suitable for IVM treatment based on anti-Mullerian hormone and antral follicle count [J]. Human reproduction (Oxford, England), 2013; 28(5): 1261\u20136.","DOI":"10.1093\/humrep\/det034"},{"issue":"8","key":"2033_CR31","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3760\/cma.j.cn101441-20210306-00102","volume":"42","author":"T Liu","year":"2022","unstructured":"Liu T, Liu D, Song X, et al. Relationship between the number of oocytes retrieved and in vitro maturation outcomes in patients with polycystic ovary syndrome undergoing natural cycles [J]. Chin J Reprod Contracept. 2022;42(8):782\u201390. https:\/\/doi.org\/10.3760\/cma.j.cn101441-20210306-00102.","journal-title":"Chin J Reprod Contracept"},{"key":"2033_CR32","doi-asserted-by":"crossref","unstructured":"Sun XY, Lan YZ, Liu S et al. Relationship Between Anti-M\u00fcllerian Hormone and In Vitro Fertilization-Embryo Transfer in Clinical Pregnancy [J]. Front Endocrinol (Lausanne), 2020;11(595448).","DOI":"10.3389\/fendo.2020.595448"},{"issue":"5 Suppl","key":"2033_CR33","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.fertnstert.2007.03.066","volume":"89","author":"MP Grossman","year":"2008","unstructured":"Grossman MP, Nakajima St Fau - Fallat ME, Fallat Me Fau - Siow Y, et al. M\u00fcllerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture [J]. Fertil Steril. 2008;89(5 Suppl):1364\u201370. https:\/\/doi.org\/10.1016\/j.fertnstert.2007.03.066.","journal-title":"Fertil Steril"},{"issue":"2","key":"2033_CR34","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.fertnstert.2013.04.019","volume":"100","author":"HM Chang","year":"2013","unstructured":"Chang HM, Klausen C, Fau - Leung PCK, Leung PC. Antim\u00fcllerian hormone inhibits follicle-stimulating hormone-induced adenylyl cyclase activation, aromatase expression, and estradiol production in human granulosa-lutein cells [J]. Fertil Steril. 2013;100(2):585\u201392. https:\/\/doi.org\/10.1016\/j.fertnstert.2013.04.019.","journal-title":"Fertil Steril"},{"issue":"1","key":"2033_CR35","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.rbmo.2021.08.016","volume":"44","author":"HW Tsai","year":"2022","unstructured":"Tsai HW, Liao PF, Li CJ, et al. High serum anti-M\u00fcllerian hormone concentrations have a negative impact on fertilization and embryo development rates [J]. Reprod Biomed Online. 2022;44(1):171\u20136. https:\/\/doi.org\/10.1016\/j.rbmo.2021.08.016.","journal-title":"Reprod Biomed Online"},{"issue":"7","key":"2033_CR36","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1007\/s10815-021-02217-x","volume":"38","author":"S Vagios","year":"2021","unstructured":"Vagios S, Sacha CR, Hammer KC, et al. Response to ovulation induction treatments in women with polycystic ovary syndrome as a function of serum anti-M\u00fcllerian hormone levels [J]. J Assist Reprod Genet. 2021;38(7):1827\u201333.","journal-title":"J Assist Reprod Genet"},{"issue":"5","key":"2033_CR37","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.fertnstert.2011.08.015","volume":"96","author":"L Pellatt","year":"2011","unstructured":"Pellatt L, Rice S, Fau - Dilaver N, Dilaver N, Fau - Heshri A, et al. Anti-M\u00fcllerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells [J]. Fertil Steril. 2011;96(5):1246\u201351. https:\/\/doi.org\/10.1016\/j.fertnstert.2011.08.015.","journal-title":"Fertil Steril"},{"key":"2033_CR38","doi-asserted-by":"publisher","unstructured":"Yu X, Li Z, Zhao X et al. Anti-M\u00fcllerian Hormone Inhibits FSH-Induced Cumulus Oocyte Complex In Vitro Maturation and Cumulus Expansion in Mice. LID\u2009\u2013\u200910.3390\/ani12091209 [doi] LID\u2009\u2013\u20091209 [J]. Animals (Basel), 2022; 12(9): 1209. https:\/\/doi.org\/10.3390\/ani12091209.","DOI":"10.3390\/ani12091209"},{"issue":"2","key":"2033_CR39","doi-asserted-by":"publisher","first-page":"299","DOI":"10.5935\/1518-0557.20230059","volume":"28","author":"LC Delamuta","year":"2024","unstructured":"Delamuta LC, Fassolas G, Dias J\u00fanior JA, et al. Antim\u00fcllerian hormone levels and IVF outcomes in polycystic ovary syndrome women: a scoping review [J]. JBRA Assist Reprod. 2024;28(2):299\u2013305. https:\/\/doi.org\/10.5935\/1518-0557.20230059.","journal-title":"JBRA Assist Reprod"},{"issue":"2","key":"2033_CR40","doi-asserted-by":"publisher","first-page":"126","DOI":"10.5653\/cerm.2016.43.2.126","volume":"43","author":"HH Seok","year":"2016","unstructured":"Seok HH, Song H, Lyu SW, et al. Application of serum anti-M\u00fcllerian hormone levels in selecting patients with polycystic ovary syndrome for in vitro maturation treatment [J]. Clin Exp Reprod Med. 2016;43(2):126\u201332.","journal-title":"Clin Exp Reprod Med"},{"issue":"3","key":"2033_CR41","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/humrep\/dead273","volume":"39","author":"L Mostinckx","year":"2024","unstructured":"Mostinckx L, Goyens E, Mackens S, et al. Clinical outcomes from ART in predicted hyperresponders: in vitro maturation of oocytes versus conventional ovarian stimulation for IVF\/ICSI [J]. Hum Reprod. 2024;39(3):586\u201394. https:\/\/doi.org\/10.1093\/humrep\/dead273.","journal-title":"Hum Reprod"},{"issue":"4","key":"2033_CR42","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.fertnstert.2013.06.018","volume":"100","author":"C Ortega-Hrepich","year":"2013","unstructured":"Ortega-Hrepich C. A freeze-all embryo strategy after in vitro maturation: a novel approach in women with polycystic ovary syndrome? [J]. Fertil Steril. 2013;100(4):1002\u20137.","journal-title":"Fertil Steril"},{"issue":"6","key":"2033_CR43","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s10815-021-02180-7","volume":"38","author":"LA Vuong","year":"2021","unstructured":"Vuong LA, Nguyen LK, Le AH, et al. Fresh embryo transfer versus freeze-only after in vitro maturation with a pre-maturation step in women with high antral follicle count: a randomized controlled pilot study [J]. J Assist Reprod Genet. 2021;38(6):1293\u2013302.","journal-title":"J Assist Reprod Genet"},{"issue":"1","key":"2033_CR44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/ijms27010005","volume":"27","author":"M Gargallo-Alonso","year":"2025","unstructured":"Gargallo-Alonso M, Picton HM, Malo C, Advances. Mechanisms, and clinical perspectives for the in vitro maturation of human Oocytes. LID\u2009\u2013\u200910.3390\/ijms27010005 [doi] LID\u2009\u2013\u20095 [J]. Int J Mol Sci. 2025;27(1):5. https:\/\/doi.org\/10.3390\/ijms27010005.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2033_CR45","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.fertnstert.2019.09.039","volume":"113","author":"KL Hu","year":"2020","unstructured":"Hu KL, Liu FT, Xu H, et al. High antim\u00fcllerian hormone levels are associated with preterm delivery in patients with polycystic ovary syndrome [J]. Fertil Steril. 2020;113(2):444\u201352.","journal-title":"Fertil Steril"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-026-02033-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02033-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02033-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:51:26Z","timestamp":1781635886000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13048-026-02033-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2033"],"URL":"https:\/\/doi.org\/10.1186\/s13048-026-02033-w","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by the Ethics Committee of Peking University Third Hospital (Ethical number: 20250616-02022-0051). Clinical trial number: not applicable. Human Ethics and Consent Participate declarations: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"126"}}